Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GSK - Compugen gains on takeover speculation after iTeos Therapeutics deal

GSK - Compugen gains on takeover speculation after iTeos Therapeutics deal

GlaxoSmithKline PLC
Compugen (CGEN) jumped 5.3% on some takeover speculation following GlaxoSmithKline's (GSK) agreement with iTeos Therapeutics (ITOS) to jointly develop and commercialize EOS-448 an anti-TIGIT monoclonal antibody currently undergoing Phase 1 studies as a potential cancer therapy.Compugen is another anti-TIGIT antibody that big pharma may be interested in, according Dealreporter's morning flash piece.iTeos surged 32%.Last week, Compugen reported updated COM701 data from Phase 1 study at ASCO21.

For further details see:

Compugen gains on takeover speculation after iTeos Therapeutics deal
Stock Information
Company Name: GlaxoSmithKline PLC
Stock Symbol: GSK
Market: NYSE
Website: gsk.com
Menu
GSK GSK Quote GSK Short GSK News GSK Articles GSK Message Board
Get GSK Alerts

News, Short Squeeze, Breakout and More Instantly...